Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
Xinfeng GuoClayton A WileyRichard A SteinmanYi ShengBeihong JiJunmei WangLiyong ZhangTony WangMazen ZenataiTimothy R BilliarQingde WangPublished in: Journal of neuroinflammation (2021)
We demonstrated that an AGS-associated mutation in ADAR1, specifically the p.K999N mutation, activates the IFN pathway in the mouse brain. The ADAR1 p.K999N mutant mouse replicates aspects of the brain interferonopathy of AGS. Neurons and microglia express different ISGs. Basal ganglia calcification and leukodystrophy seen in AGS patients were not observed in K999N mutant mice, indicating that development of the full clinical phenotype may need an additional stimulus besides AGS mutations. This mutant mouse presents a robust tool for the investigation of AGS and neuroinflammatory diseases including the modeling of potential "second hits" that enable severe phenotypes of clinically variable diseases.
Keyphrases
- immune response
- wild type
- end stage renal disease
- chronic kidney disease
- dendritic cells
- ejection fraction
- newly diagnosed
- prognostic factors
- spinal cord
- peritoneal dialysis
- toll like receptor
- resting state
- inflammatory response
- white matter
- genome wide
- copy number
- spinal cord injury
- functional connectivity
- case report
- multiple sclerosis
- drug induced
- transcription factor